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ABSTRACT 
Objective: The present study was focused to screen traditionally used Barleria prionitis for anticancer effects against various cell lines and 
antimicrobial effect against various pathogenic strains of bacteria and fungi. 
Methods: Extraction of Barleria prionitis leaves in ethanol was done by the Soxhlet method. After extraction, phytochemical estimation of these 
seven secondary metabolites like alkaloids, flavonoids, anthraquinones, saponins, terpenoids, tannins, and cardiac glycosides was done as per the 
protocols of Kokate. Minimum Inhibitory Concentration (MIC) effect of Barleria leaf ethanol (BLE) was done by the dilution method on five bacterial 
and five fungal strains. Further analysis (anticancer activity) was done with SRB (Sulphorhodamine B) assay. Statistical analysis of antimicrobial 
and anticancer activity was done by using MS Excel 2007 to±standard deviation and student t-test. 
Results: Barleria leaf extract with ethanol is a non-polar solvent extract and considered as the best solvent to extract the maximum number 
of secondary metabolites like alkaloids, saponins, flavonoids, and tannins. BLE extract gave excellent MIC (Minimum Inhibitory 
Concentration) effects against pathogenic bacteria and pathogenic fungal strains. BLE had highly effective activity against Pseudomonas 
aeruginosa with 1.25 mg MIC, the OD value of the sample was 0.02±0.0005 (±SD) with 0.0211-0.0245 range. MIC against fungal strains had 
effective activity against Candida vaginitis with 6.25 mg, the OD value of the sample was 0.02±0.0003 (±SD) with 0.0213-0.0232 range. BLE 
extract had given more than 70% inhibition against breast cell lines (MCF-7) and 75.16% inhibition of DLD1 cell lines; it was near to 
Doxorubicin antibiotic (81%). Breast metastatic cell line (MDMAMB-468) was found 60% inhibited with BLE extract and there was a great 
difference in the results of Doxorubicin. Out of six experimented cell lines, BLE gave very good inhibition for two cell lines, i.e. Breast (MCF-
7) and Colon cell lines (DLD-1). 
Conclusion: BLE extract had shown the best antimicrobial and antifungal effect, against Pseudomonas aeruginosa and Candida vaginitis respectively. 
BLE also showed an anticancer effect against Lung cell lines (A549), Breast cancer cell line (MCF-7), Breast metastatic cell line (MDMAMB-468), 
Colon cell line (DLD-1) and lung metastatic cell line (NCIH358) at a statistically significant level (p=<0.05). It did not give any significant results 
against the colon metastatic cell line (SW620). 
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According to all India ethnobiological survey carried out by the 
ministry of environment and forest, Government of India, there are 
over 8000 species of medicinal plants being used by people of India. 
Medicinal plants are used as a natural source to combat against 
various diseases like diabetes, asthma, diarrhea, cancer, etc. U. S 
National Cancer Institute (NCI) in 1957 launched a step to find out 
anticancer agents from higher plants. Today, most of the useful and 
creative drugs can be derived from higher altitude plants as natural 
products [1]. Global scenario indicated that breast cancer and 
colorectal cancer is the most prominent cancer in case of both 
women and men [2]. 
Barleria prionitis is an Ayurvedic herb distributed in the tropical 
Asia, Africa, and Yemen. The whole plant or its specific parts (leaf, 
stem, bark, and flower) have been used for the treatment of 
toothache, jaundice, fever, gastrointestinal disorder, etc. [3]. 
Phytochemical constituents and extracts of this plant have 
infatuated wide range of pharmacological include antimicrobial, 
anti-arthritic cytoprotective, hepatoprotective, diuretic, 
antidiarrheal, enzyme inhibitory and antinociceptive activities 
without any toxic effects. It was observed that the leaves showed 
higher degree antioxidant potential and phenolic content in 
comparison to flower and stem [4]. Barleria prionitis occupy a 
significant place in the Ayurvedic medicine in India; it has been used 
as traditionally due to its Phytochemistry, pharmacology, and 
toxicity. In a recent study, Barleria prionitis has also shown good 
antimicrobial activity against various strains by using the gradient 
plate technique method [12]. 
The present study was focused to screen traditionally used Barleria 
prionitis for anticancer effects against various cell lines and 
antimicrobial effect against various bacterial and fungal strains. 
MATERIALS AND METHODS 
Chemicals and reagents 
Ethanol (LC-MS grade), Distilled water (Millipore, Milford, MA, USA), 
broth (Mueller Hinton broth), culture medium for cell lines (RPMI-
1640 with 5% FBS), spectrophotometer (API 4000 QTRAPTM
Procurement of plant material 
MS/MS 
system from AB Sciex, Concord, ON, Canada), Plate reader for cell 
lines (Epoch Microplate reader, Biotek, USA). 
The plant was collected from the government nursery of Modinagar, 
Dist. Ghaziabad, U. P, India and authenticated by NBRI, Lucknow, 
India (Voucher/Specimen no. is NBRI-SOP-202), a voucher specimen 
was deposited in the department. 
Extraction 
The plant’s part (Leaves) was separated from the plant and washed 
carefully under running tap water followed by distilled water. These 
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were dried in 45 °C for one week and pulverized to a fine powder 
using a sterilized mixer grinder. Then the 50 g powder of the leaves 
was extracted by the Soxhlet method in ethanol, which was taken on 
the basis of their polarity 19.4. 
Qualitative phytochemical investigation of extract 
A qualitative chemical test was conducted, to check the presence of 
the various phytochemical constituents. The presence of various 
phytochemicals found in the extract is given in table 1 for a 
qualitative screening known amount of 20 mg [5]. 
Minimum inhibitory concentration against bacterial and fungal 
strains 
Collection of strains 
The bacterial pathogens strains Cornybacterium diphtheria: MTCC 
116, Pseudomonas aeruginosa: MTCC 10462, Bacillus thruengiensis: 
MTCC 10484, Bacillus anthracis: MTCC 10095, Salmonella typhi: 
MTCC3231, Chlamydia pneumonia: MTCC 7162 and fungal strains 
like Aspergillus fumigatus: MTCC 4163, Cryptococcus neoformans: 
MTCC 63333, Candida albicans: MTCC 7253 were collected from 
innovative life sciences, Lucknow and Candida vaginitis: Clinical 
isolate, Blastomyces dermatitidis: Clinical isolate, Gaurang Homeo 
Clinic, Aliganj, Sector-1, Lucknow 226010, Uttar Pradesh. 
Screening of bioactive compounds against various microbes 
The method used to screen plant extracts before determination of 
MIC was agar well diffusion method, in which 25 ml of nutrient agar 
media poured in a sterile Petri dish, 100μl of test organisms were 
spread on the surface of media, wells were prepared with the help of 
sterile borer and wells were aseptically filled with 50μl of plant 
extract along with positive (antibacterial compound tetracycline and 
antifungal compound fluconazole at 50μg/ml and 100μg/ml 
respectively) and negative control (autoclaved DMSO). Plates were 
incubated aerobically at 37 °C/25 °C as bacteria/fungus culture for 
72 h. The diameter of zones of inhibition was measured, and I found 
the initial concentration of MIC was 10 mg/ml for bacterial strains 
and 20 mg/ml for fungal strains 
Preparation of bacterial/fungal strains and culture conditions  
All the cultures were obtained from Lucknow, India. Cultures of 
Salmonella typhi, Chlamydia pneumoniae, Bacillus thruengiensis, 
Bacillus anthracis, and Pseudomonas aeruginosa were maintained on 
the nutrient agar medium and fungal strains of Aspergillus 
fumigatus, Candida neoformans, Candida albicans, Candida vaginitis, 
Blastomyces dermatitidis on Potato Dextrose agar medium by 
making slants, and the stock cultures were sub cultured at monthly 
intervals. 
Dilution method 
3 ml of nutrient broth (for bacterial cultures) and Potato Dextrose 
(for fungal strains) were taken in 5 test tubes, sterilized by 
autoclave. Plant extracts with a final concentration of 100 mg/ml 
(for bacterial pathogens) and Plant extracts with a final 
concentration of 200 mg/ml (for fungal pathogens) were mixed with 
another extra 3 ml of liquid media (Potato Dextrose, PD) and liquid 
media (Nutrient Broth). 1 ml culture was added into the first tube, 
mixed properly, and after mixing; 3 ml of the solution was taken 
from the first test tube and transferred to the second test tube. The 
same was repeated up to the 5th
Statistical analysis was done in triplicate, and the data were 
expressed as the mean±standard deviation with range. Analysis of 
this study was done using the Statistical Package for the Social 
sciences (SPSS) Version 20.0 and MS Excel 2007. One way ANOVA 
followed by Turkey’s honestly significant difference post hoc test 
was used to compare the data, in which p values were considered 
significant at a 95% confidence interval (p<0.05). 
Total activity 
Total activity is the volume at which the test extract can be 
diluted with the ability to kill microorganisms. It was calculated 
by dividing the amount of extract from 1g plant material by the 
MIC of the same extract or compound isolated and is expressed 
in ml/g [7]. 
 test tube, followed by removal of an 
extra 3 ml solution from last test tube to keep the media volume 
constant. 
30 µl of fresh culture was added to all of the test tubes and were 
incubated at 37 °C for overnight. The inhibition of growth of 
pathogens was recorded in terms of optical density at 600 nm. The 
concentration of plant extract just before the test tube showing 




The cell lines were collected from the Biochemistry Division, CSIR-
Central Drug Research Institute (CDRI), Lucknow and also preceded 
at CDRI under the supervision of Dr. Dipak Datta and his Technician 
Mr. Sanjeev Meena. 
Preparation of test sample 
The test samples/molecules were weighed in microcentrifuge tubes 
and stock solutions of 50 mg/ml made by dissolving the samples in 
DMSO. Stocks were stored at-20 °C. A working solution of 200 μg/ml 
concentration was made by diluting the stock solution in culture 
medium prior to the assay. 
Sulforhodamine B (SRB) assay (Addition of cells) 
The human cancer cell lines Breast (MCF-7), Colon (DLD-1), Lung 
(A549), Breast Metastatic (MDMAMB-468) and Lung Metastatic 
(NCIH358) were maintained in RPMI-1640 medium. Colon 
Metastatic (SW620) cell lines were maintained in DMEM medium. 
The enumerated cells were dispensed in a 96-well tissue culture 
plate; each well receives 100 µl. 
Addition of test sample 
100 µl of working solution of the test sample was added to the cell 
monolayer to give a final concentration of 100 μg/ml for each 
sample; duplicate wells were included. 
Addition of SRB and calorimetric reading 
After 48 h incubation, cells attached to the substratum of the plate 
were fixed by adding cold 50% trichloroacetic acid (TCA, 50 µl/well) 
on top of the medium and incubated at 4 °C for 1h. After that, the 
plate was gently washed 5 times with slow running tap water via 
plastic tubing to remove TCA, culture medium and dead cells. After 
washing, the plates were allowed to dry in air. To dry plates, 50 
µl/well of SRB solution was added and left at room temperature for 
30 min. At the end of the staining period, unbound SRB was removed 
by quickly rinsing plates 4-5 times with 1% (v/v) acetic acid.  
Plates were allowed to air-dry at room temperature. 150 µl of 10 
mmol Tris base solution was added to each well and the plate was 
shaken for 15 min on a gyratory shaker to solubilize the protein-
bound dye. Absorbance was measured at 510 nm in a microplate 
spectrophotometer. 
Data analysis 
Percentage of cell growth inhibition in the presence of the test 
sample was calculated as follows:  
 
Statistical analysis 
Statistical analysis was done using IBM SPSS statistics 20.0 and MS 
Excel 2007 with a range (±standard deviation). 
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RESULTS 
Table 1: Phytochemical estimation of Barleria prionitis leaf ethanol extract 
S. No. Secondary metabolites Method Results 
1 Alkaloids Hager’s method and Tannic acid Positive 
2 Saponins Foam test Positive 
3 Steroids Salkowaski reaction Negative 
4 Flavonoids Shindona test and Sodium hydroxide test  Positive 
5 Tannins Lead Acetate test Positive 
6 Cd. Glycosides KellarKillani test and Baljet's test Negative 
7 Anthroquinone Confirmation test from kokate.(Pharmacology Hand Book) Negative 
 
Table 2: MIC of Barleria prionitis leaf ethanol extracts against bacteria strains 
S. 
No. 




































0±0.0002 0.0±0.0001 0.02±0.0005 0.01±0.0003 0.02±0.0005 0.61 NG 1.2

















*±Standard Deviation with range, n= 5 NG= No growth, MIC=Minimum Inhibitory Concentration, Negative control=DMSO 
 



















































*±Standard Deviation with range, n=5, NG= No growth, MIC=Minimum Inhibitory Concentration, Negative control=DMSO 
 
Table 4: Total activity of BLE for bacteria 
Pathogen details Total activity 
S. No. Strains T A MIC 
1 S. typhi 214.4 2.5 
2 C. pneumoniae 107.2 5 
3 B. thruengiensis 214.4 2.5 
4 P. aeruginosa 428.8 1.25 
5 C. diphtheria 214.4 2.5 
 
Table 5: Total activity of BLE for fungi 
Pathogen details Total activity 
S. No. Strains T A MIC 
1 A. fumigatus 42.88 12.5 
2 C. neoformans 42.88 12.5 
3 C. albicans 42.88 12.5 
4 C. vaginitis 85.76 6.25 
5 B. dermatitidis 42.88 12.5 
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Fig. 1: Percent Inhibition activity for anticancer effects of BLE and doxorubicin drug against cancer cell lines and metastatic cancer cell 
lines, *
 
±standard deviation with mean, n= 3 
DISCUSSION  
Barleria leaf extract with ethanol is a non-polar solvent extract and 
considered as the best solvent to extract a maximum number of 
secondary metabolites (4/7) i.e. alkaloids, saponins, flavonoids, and 
tannins. In various other studies, phytochemicals such as alkaloids, 
saponins, flavonoids, sterols, tannins, and anthraquinone were 
extracted as a secondary metabolite from BLE [8-10]. 
BLE extract showed good MIC effects against pathogenic bacterial and 
pathogenic fungal strains. This effect occurred due to the presence of 
alkaloids, saponins, flavonoids, and tannins (individually or in 
combination). Table 2 shows the results of MIC against bacterial 
strains. In which, BLE had high antimicrobial activity against 
Pseudomonas aeruginosa with 1.25 mg MIC, the OD value of the sample 
was 0.02±0.0005 (±SD) with 0.0211-0.0245 range. Table 3 shows the 
results of MIC against fungal strains. In which, BLE had high antifungal 
activity against Candida vaginitis with 6.25 mg MIC, OD value of the 
sample is 0.02±0.0003 (±SD) with 0.0213-0.0232 range. BLE was very 
effective against C. Vaginitis, and A. fumigates but showed the 
moderate effect against B. dermatitidis, C. albicans, and C. neoformans. 
Barleria leaf ethanol extract gave more than 70% inhibition against 
Breast cell lines (MCF-7) comparable to Doxorubicin antibiotic (81%). 
Breast metastatic (MDMAMB-468) was 60% inhibited with Barleria 
leaf ethanol extract, and there was a significant difference in the 
results of Doxorubicin. Barleria leaf with ethanol (BLE) gave very good 
inhibition for two cell lines i.e. Breast (MCF-7) and Colon cell lines 
(DLD-1) out of six cell lines. Barleria prionitis was found inactive for 
anticancer effects in reported study methanol extracts of leaf [11]. 
CONCLUSION 
Barleria leaf ethanol (BLE) extract had given best inhibitory effects 
against Pseudomonas aeruginosa in the study included bacterial 
strains. Candida vaginitis has been found to be best sensitive strain 
than other experimental fungal strain included in our study. BLE 
was found to be the best anti-cancer activity against most 
experimented cancer cell lines included in our study like Lung cell 
line (A549), Breast cell line (MCF-7), Breast metastatic cell line 
(MDMAMB-468), Colon cell line (DLD-1) and lung metastatic cell line 
(NCIH358) with (p<0.05) significance. It did not give any significant 
results against colon metastatic cell lines (SW620). The study would 
provide further insight in the development of herbal as well as other 
drugs and therapies for the treatment of various types of cancer and 
other diseases. 
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